Evidence map›Paper›PMID 31822288›Full record

ArticleBMC complementary and alternative medicine2019

Oolong tea consumption and its interactions with a novel composite index on esophageal squamous cell carcinoma.

Shuang Liu, Zheng Lin, Liping Huang, Huilin Chen, Yanfang Liu, Fei He, Xiane Peng, Weilin Chen, Ruigang Huang, Wanting Lu and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Shuang LiuDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Zheng LinDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Liping HuangDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Huilin ChenDepartment of Radiation Oncology, Anxi County Hospital, Quanzhou, 352400, China.
Yanfang LiuDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Fei HeDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Xiane PengDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Weilin ChenDepartment of Radiation Oncology, Zhangzhou Affliated Hospital of Fujian Medical University, Zhangzhou, 363000, China.
Ruigang HuangDepartment of Radiation Oncology, Zhangzhou Affliated Hospital of Fujian Medical University, Zhangzhou, 363000, China.
Wanting LuDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Huimin YangDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Zhisheng XiangDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Zhihui ZhangDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China.
Zhijian HuDepartment of Epidemiology and Health Statistics, Fujian Medical University Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of public Health, Fujian Medical University, Fuzhou, 350108, China. huzhijian@fjmu.edu.cn.
Fujian Medical University · CNZhangzhou Municipal Hospital of Fujian Province · CN

Funding

SUBTHRESHOLD MUSCLE AFFERENT INPUT TO DORSAL HORNF06TW002012 · FIC · UNIVERSITY OF CALIFORNIA DAVIS · PI KAUFMAN, MARC PETER · 1995 to 1995
–
Medical Innovation project of Fujian Province 2018-CX-38National Key R&D Program of China 2017YFC0907100Natural Science Foundation of Fujian Province 2015J01305Startup Fund for scientific research, Fujian Medical University 2018QH2012
6 · The paper itself

Abstract

backgroundNo previous study has investigated the association between oolong tea consumption and esophageal squamous cell carcinoma (ESCC), we aim to elucidate the association between oolong tea consumption and ESCC and its joint effects with a novel composite index.

methodsIn a hospital-based case-control study, 646 cases of ESCC patients and 646 sex and age matched controls were recruited. A composite index was calculated to evaluate the role of demographic characteristics and life exposure factors in ESCC. Unconditional logistic regression was used to calculate the point estimates between oolong tea consumption and risk of ESCC.

resultsNo statistically significant association was found between oolong tea consumption and ESCC (OR = 1.39, 95% CI: 0.94-2.05). However, drinking hot oolong tea associated with increased risk of ESCC (OR = 1.60, 95% Cl: 1.06-2.41). Furthermore, drinking hot oolong tea increased ESCC risk in the high-risk group (composite index> 0.55) (OR = 3.14, 95% CI: 1.93-5.11), but not in the low-risk group (composite index≤0.55) (OR = 1.16, 95% CI: 0.74-1.83). Drinking warm oolong tea did not influence the risk of ESCC.

conclusionsNo association between oolong tea consumption and risk of ESCC were found, however, drinking hot oolong tea significantly increased the risk of ESCC, especially in high-risk populations.

Indexed as

TeaCase-Control StudiesDietEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleHot TemperatureHumansMaleMiddle AgedOdds RatioTeaCase-control studyESCCOolong tea consumptionThe risk index

Identifiers

PMID31822288
PMCPMC6902529
OpenAlexW2995842416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.